STREAMEX CORP. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
STREAMEX CORP. (STEX) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $3.21 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-14
- STREAMEX CORP. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $3.21.
- STREAMEX CORP. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $1.25, a 14.97% decline year-over-year.
- STREAMEX CORP. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-03-31 was $1.47, a 66.44% decline year-over-year.
- STREAMEX CORP. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2021-03-31 was $4.38, a 9.23% increase year-over-year.
- STREAMEX CORP. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $0.84, a 86.67% increase from fiscal 2024.
- STREAMEX CORP. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $0.45, a 95.50% decline from fiscal 2023.
- STREAMEX CORP. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $10.00, a 10.71% decline from fiscal 2022.
- STREAMEX CORP. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $11.20, a 203.52% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.21 10-Q · filed 2026-08-14 | |||||
| 2026-03-31 | $3.21 10-Q · filed 2026-05-14 | |||||
| 2025-12-31 | $0.84 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | $0.84 10-Q · filed 2025-11-14 | |||||
| 2025-06-30 | $0.84 10-Q · filed 2025-08-15 | |||||
| 2024-12-31 | $0.45 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | $0.45 10-Q · filed 2024-11-14 | |||||
| 2023-12-31 | $10.00 10-K · filed 2025-04-15 | |||||
| 2023-09-30 | $1.33 10-Q · filed 2023-11-14 | |||||
| 2023-06-30 | $1.34 10-Q · filed 2023-08-14 | |||||
| 2023-03-31 | $1.25 10-Q · filed 2023-05-15 | |||||
| 2022-12-31 | $11.20 10-K · filed 2024-04-16 | $1.12 10-K · filed 2023-03-31 | ||||
| 2022-09-30 | $1.20 10-Q · filed 2022-11-14 | |||||
| 2022-06-30 | $1.23 10-Q · filed 2022-08-15 | |||||
| 2022-03-31 | $1.47 10-Q · filed 2022-05-16 | |||||
| 2021-12-31 | $3.69 10-K · filed 2023-03-31 | |||||
| 2021-12-28 | $2.44 10-K · filed 2022-03-31 | |||||
| 2021-10-04 | $2.89 10-K · filed 2022-03-31 | |||||
| 2021-09-30 | $3.39 10-Q · filed 2021-11-15 | |||||
| 2021-06-30 | $4.14 10-Q · filed 2021-08-11 | |||||
| 2021-03-31 | $4.38 10-Q · filed 2021-05-17 | |||||
| 2020-12-31 | $4.98 10-K · filed 2022-03-31 | |||||
| 2020-09-30 | $5.59 10-Q · filed 2020-11-05 | |||||
| 2020-06-30 | $4.96 10-Q · filed 2020-08-06 | |||||
| 2020-06-02 | $10.00 10-Q · filed 2020-11-05 | |||||
| 2020-05-05 | $5.00 10-Q · filed 2020-11-05 | |||||
| 2020-04-29 | $5.00 10-Q · filed 2020-11-05 | |||||
| 2020-04-21 | $5.00 10-Q · filed 2020-11-05 | |||||
| 2020-03-31 | $4.01 10-Q · filed 2020-05-11 | |||||
| 2019-12-31 | $5.99 10-K · filed 2021-03-15 | |||||
| 2019-03-31 | $4.90 10-Q · filed 2019-04-15 | |||||
| 2018-12-31 | $4.65 10-K · filed 2020-03-13 | |||||
| 2018-10-16 | $5.09 10-K · filed 2019-03-15 | |||||
| 2018-09-30 | $4.38 10-Q · filed 2018-11-02 | |||||
| 2018-06-30 | $1.75 10-Q · filed 2018-07-27 | |||||
| 2018-03-31 | $1.42 10-Q · filed 2018-05-04 | |||||
| 2017-12-31 | $3.75 10-K · filed 2019-03-15 | $1.50 10-K · filed 2018-02-27 | ||||
| 2017-11-24 | $3.63 10-K · filed 2019-03-15 | |||||
| 2017-11-08 | $3.92 10-K · filed 2019-03-15 | |||||
| 2016-12-31 | $1.71 10-K · filed 2018-02-27 | |||||
| 2016-12-29 | $1.35 10-K · filed 2018-02-27 | |||||
| 2016-12-22 | $1.36 10-K · filed 2018-02-27 | |||||
| 2016-12-08 | $1.36 10-K · filed 2017-04-11 | |||||
| 2016-09-30 | $1.80 10-Q · filed 2016-11-14 | |||||
| 2016-06-30 | $1.84 10-Q · filed 2016-08-12 | |||||
| 2015-12-31 | $2.70 10-K · filed 2017-04-11 | |||||
| 2015-09-30 | $2.70 10-Q · filed 2015-11-13 | |||||
| 2015-06-30 | $2.75 10-Q · filed 2015-07-28 | |||||
| 2015-03-31 | $2.47 10-Q · filed 2015-05-01 | |||||
| 2014-12-31 | $2.39 10-K · filed 2016-03-14 | |||||
| 2014-09-30 | $2.43 10-Q · filed 2014-10-17 | |||||
| 2013-12-31 | $2.09 10-K · filed 2015-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |